NCT04145349 2025-12-08CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell TumorEli Lilly and CompanyPhase 1/2 Active not recruiting30 enrolled 16 charts
NCT01222715 2017-05-05Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory RhabdomyosarcomaNational Cancer Institute (NCI)Phase 2 Completed87 enrolled 11 charts